Morgan Stanley analyst Michael Ulz reiterated a Buy rating on Sarepta Therapeutics (SRPT – Research Report) today and set a price target ...

Analyst Gena Wang of Barclays maintained a Buy rating on Sarepta Therapeutics (SRPT – Research Report), retaining the price target of ...

On Thursday, Sarepta Therapeutics Inc (SRPT) stock saw a modest uptick, ending the day at $122.41 which represents a slight increase of $4.42 or 3.75% from the prior close of $117.99. The stock opened ...

innovation capabilities, and adaptability to shifting economic landscapes. Name Revenue Growth Earnings Growth Growth Rating Clinuvel Pharmaceuticals 22.32% 27.42% Sarepta Therapeutics 23.67% ...

Capricor Therapeutics (NASDAQ:CAPR) stock rose 5% in midday trading Friday after the company reported positive long-term data ...

Six years ago, Sanofi gave $125 million and promised over $1 billion in milestone payments to buzzy neuroscience startup ...

Investing.com - Edgewise Therapeutics (NASDAQ: EWTX) reported fourth quarter EPS of $-0.34, in line with the analyst estimate of $-0.34. Revenue for the quarter came ...

While Milton did not trigger the catastrophic surge of seawater feared in Florida, the clean-up operation could take many weeks or months. United Statescategory Trump expected to play up fears of ...

A Woman Won South Korea’s First Literature Nobel. That Says a Lot. While Han Kang’s victory was celebrated as a crowning cultural achievement for her country, her work also represents a form ...

In the last weeks of the presidential campaign, the world’s richest man has involved himself in the U.S. election in a manner unparalleled in modern history. 7 min read A Misleading Question ...

Jobless rate drops to 6.5% in September. What that means for rate cut hopes Jobless rate drops to 6.5% in September. What that means for rate cut hopes Statistics Canada said Friday that job gains ...

49 years ago today, Saturday Night Live premiered on NBC with George Carlin as host. The seminal comedy television program in American history, SNL ...